Blockade of Type 2A Protein Phosphatase Signaling Attenuates Complement C1q-Mediated Microglial Phagocytosis of Glutamatergic Synapses Induced by Amyloid Fibrils

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2022 Dec 14

PMID 36515857

Authors

Jiang Wu

Jijun Xu

Mohamed Naguib

Bihua Bie

Affiliations

Soon will be listed here.

Abstract

We previously reported the critical involvement of metabotropic GluR1 (mGluR1) signaling in complement C1q-dependent microglial phagocytosis of glutamatergic synapses in a rat model of Alzheimer's disease (AD) injected with amyloid fibrils. Here, we explored the role of type 2A protein phosphatase (type 2A PPase), a key enzyme downstream of mGluR1 signaling, in the pathogenesis of AD in rats. Significant local upregulation of PP2A expression was observed in the hippocampal CA1 after bilateral microinjection of amyloid-beta (Aβ) fibrils. Amyloid fibrils induced remarkable dephosphorylation of pFMRP (fragile X mental retardation protein) and C1q upregulation in hippocampal glutamatergic synapses, which was ameliorated by microinjection of type 2A PPase inhibitor okadaic acid (OA). Microinjection of OA further attenuated the microglial phagocytosis of glutamatergic synapses, recovered the hippocampal glutamatergic transmission, and improved the performance in Morris water maze test. These findings demonstrated that dysfunction of type 2A PPase signaling contributed to complement C1q-dependent microglial phagocytosis of glutamatergic synapses and the cognitive impairments in the rat model of AD.

Citing Articles

Microglia and Astrocytes in Alzheimer's Disease: Significance and Summary of Recent Advances.

Deng Q, Wu C, Parker E, Liu T, Duan R, Yang L Aging Dis. 2023; 15(4):1537-1564.

PMID: 37815901 PMC: 11272214. DOI: 10.14336/AD.2023.0907.

Axonal and presynaptic FMRP: Localization, signal, and functional implications.

Wang X, Sela-Donenfeld D, Wang Y Hear Res. 2023; 430:108720.

PMID: 36809742 PMC: 9998378. DOI: 10.1016/j.heares.2023.108720.

References

Lui H, Zhang J, Makinson S, Cahill M, Kelley K, Huang H . Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016; 165(4):921-35. PMC: 4860138. DOI: 10.1016/j.cell.2016.04.001. View

Ceman S, ODonnell W, Reed M, Patton S, Pohl J, Warren S . Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet. 2003; 12(24):3295-305. DOI: 10.1093/hmg/ddg350. View

Niere F, Wilkerson J, Huber K . Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. J Neurosci. 2012; 32(17):5924-36. PMC: 3349238. DOI: 10.1523/JNEUROSCI.4650-11.2012. View

Hamilton A, Esseltine J, DeVries R, Cregan S, Ferguson S . Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease. Mol Brain. 2014; 7:40. PMC: 4050478. DOI: 10.1186/1756-6606-7-40. View

Bassell G, Warren S . Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008; 60(2):201-14. PMC: 3691995. DOI: 10.1016/j.neuron.2008.10.004. View

Javadpour P, Dargahi L, Ahmadiani A, Ghasemi R . To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling. Cell Mol Life Sci. 2019; 76(12):2277-2297. PMC: 11105459. DOI: 10.1007/s00018-019-03063-y. View

Wei H, Zhang H, Wang X, Xie J, An D, Wan L . Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models. Neurotherapeutics. 2020; 17(3):1087-1103. PMC: 7609734. DOI: 10.1007/s13311-020-00841-6. View

Schafer D, Lehrman E, Kautzman A, Koyama R, Mardinly A, Yamasaki R . Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012; 74(4):691-705. PMC: 3528177. DOI: 10.1016/j.neuron.2012.03.026. View

Li Y, Stockton M, Bhuiyan I, Eisinger B, Gao Y, Miller J . MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome. Sci Transl Med. 2016; 8(336):336ra61. PMC: 4995450. DOI: 10.1126/scitranslmed.aad9370. View

10.

Lee E, Kim H, Kuwano Y, Abdelmohsen K, Srikantan S, Subaran S . hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat Struct Mol Biol. 2010; 17(6):732-9. PMC: 2908492. DOI: 10.1038/nsmb.1815. View

11.

Bie B, Brown D, Naguib M . Increased synaptic GluR1 subunits in the anterior cingulate cortex of rats with peripheral inflammation. Eur J Pharmacol. 2010; 653(1-3):26-31. DOI: 10.1016/j.ejphar.2010.11.027. View

12.

Bie B, Wu J, Foss J, Naguib M . Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer's Rodent Models. Mol Neurobiol. 2019; 56(8):5568-5585. PMC: 6615956. DOI: 10.1007/s12035-019-1467-8. View

13.

Shin R, Ogino K, Kondo A, Saido T, Trojanowski J, Kitamoto T . Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J Neurosci. 1997; 17(21):8187-93. PMC: 6573761. View

14.

Sokol D, Maloney B, Long J, Ray B, Lahiri D . Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology. 2011; 76(15):1344-52. PMC: 3090060. DOI: 10.1212/WNL.0b013e3182166dc7. View

15.

Prickett T, Brautigan D . The alpha4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A. J Biol Chem. 2006; 281(41):30503-11. DOI: 10.1074/jbc.M601054200. View

16.

Aschrafi A, Cunningham B, Edelman G, Vanderklish P . The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci U S A. 2005; 102(6):2180-5. PMC: 548595. DOI: 10.1073/pnas.0409803102. View

17.

Hong S, Beja-Glasser V, Nfonoyim B, Frouin A, Li S, Ramakrishnan S . Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016; 352(6286):712-716. PMC: 5094372. DOI: 10.1126/science.aad8373. View

18.

Narayanan U, Nalavadi V, Nakamoto M, Pallas D, Ceman S, Bassell G . FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci. 2007; 27(52):14349-57. PMC: 6673448. DOI: 10.1523/JNEUROSCI.2969-07.2007. View

19.

Zhang M, Wang Q, Huang Y . Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells. Proc Natl Acad Sci U S A. 2007; 104(24):10057-62. PMC: 1891223. DOI: 10.1073/pnas.0700169104. View

20.

Bie B, Zhang Z, Cai Y, Zhu W, Zhang Y, Dai J . Nerve growth factor-regulated emergence of functional delta-opioid receptors. J Neurosci. 2010; 30(16):5617-28. PMC: 2865237. DOI: 10.1523/JNEUROSCI.5296-09.2010. View